---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-088431"
form_type: "8-K"
ticker: "OBIO"
cik: "0001814114"
company_name: "Orchestra BioMed Holdings, Inc."
filed_at: "2024-08-12T23:59:59+00:00"
generated_at: "2026-05-31T10:07:03.522438+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Orchestra BioMed enters $100M ATM sales agreement with TD Cowen, terminates Jefferies facility

## Summary
- New sales agreement with TD Securities (USA) LLC for up to $100M of common stock in at-the-market offerings.
- Prior $100M ATM agreement with Jefferies LLC terminated; $15.5M had been sold under it, $84.5M remained unused.
- Termination intended to eliminate restrictions on Jefferies publishing research reports on the company.
- Offering is under existing shelf registration statement (filed May 2024); no obligation to sell any shares.

## SEC filing metadata
- accession: 0001104659-24-088431
- form_type: 8-K
- ticker: OBIO
- cik: 0001814114
- company_name: Orchestra BioMed Holdings, Inc.
- filed_at: 2024-08-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1814114/000110465924088431/0001104659-24-088431-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1814114/000110465924088431/tm2421432d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-088431
- JSON: https://secwatch.observer/filing/0001104659-24-088431.json
- Plain text: https://secwatch.observer/filing/0001104659-24-088431.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.